SCOTUS asks generic Copaxone rivals for response to Teva's delay bid

Save

On Monday, Teva asked Supreme Court Chief Justice John Roberts to consider a plea to block generic competition to Copaxone until SCOTUS has weighed its appeal. And now, he wants to know what generics makers think about it.